AbbVie · San Francisco, CA

Scientist 1, Oncology | Drug Discovery at AbbVie — San Francisco, CA

Full-timeSan Francisco, CA$112,549–$112,549/yearPosted 2026-07-24Apply on SmartRecruiters

Full job description

Scientist 1, Oncology | Drug Discovery, AbbVie Biotherapeutics Inc., South San Francisco, CA: Onsite (onsite 5 days per week).

Key Responsibilities

  • Develop & optimize complex bioassays & target-binding potency assays critical for development of complex biotherapeutics. Investigate, identify, develop, and optimize new methods and techniques to generate reliable and reproducible data in a timely manner.
  • Develop new techniques, explore new approaches & technologies, perform troubleshooting & optimization experiments, & present your work to various cross-functional teams.
  • Read and adapt scientific literature to accomplish assignments and demonstrate broad and versatile technical expertise within discipline.

Education & Experience

Must possess a MS degree in biology, biochemistry, cell/molecular biology, pharmacology, &/or toxicology or a related field & 1 year working in an academic &/or industry setting as a development scientist.

Of work experience required, must have 1 year:

  • developing binding potency assays including ELISA, TR-FRET, Octet, flow cytometry, & other cell-based formats, to characterize & test protein therapeutics including monoclonal antibodies, ADCs, &/or other biologic modalities;
  • independently designing and conducting critical experiments that further project goals;
  • working in a matrixed organization within a cross-functional scientific environment within an oncology discovery research organization; &
  • authoring technical reports, drafting SOPs, writing biology sections of regulatory filings, & giving scientific presentations to peers & management.

Work experience may be gained concurrently.

Pay Rate: $112,549 per year.

Apply online at https://careers.abbvie.com/en or send resume to Job.opportunity.abbvie@abbvie.com. Refer to Req ID: REF49861T

---------------------------------------------------------------------------